Brukinsa Evrópusambandið - íslenska - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Æxlishemjandi lyf - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Stesolid Endaþarmslausn 5 mg/2,5 ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

stesolid endaþarmslausn 5 mg/2,5 ml

actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 5 mg/2,5 ml

Stesolid Endaþarmslausn 10 mg/2,5 ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

stesolid endaþarmslausn 10 mg/2,5 ml

actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 10 mg/2,5 ml

Cerdelga Evrópusambandið - íslenska - EMA (European Medicines Agency)

cerdelga

sanofi b.v. - eliglustat - gauchersjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - cerdelga er ætlað til lengri tíma meðferð fullorðinn sjúklinga með eins sjúkdómur tegund 1 (gd1), sem eru cyp2d6 léleg metabolisers (fyrirtíðaspennu), millistig metabolisers (skilaboð) eða mikla metabolisers (sjúkrabíl).

Vosevi Evrópusambandið - íslenska - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (sjá kafla 4. 2, 4. 4 og 5.